Dynamics of P2X7 receptor pore dilation: Pharmacological and functional consequences
- 1 June 2001
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 53 (2-3) , 60-65
- https://doi.org/10.1002/ddr.1171
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Apparent species differences in the kinetic properties of P2X7 receptorsBritish Journal of Pharmacology, 2000
- Maitotoxin and P2Z/P2X7purinergic receptor stimulation activate a common cytolytic poreAmerican Journal of Physiology-Cell Physiology, 1999
- Pharmacological characterization of ATP‐ and LPS‐induced IL‐1β release in human monocytesBritish Journal of Pharmacology, 1999
- Effects of antagonists at the human recombinant P2X7 receptorBritish Journal of Pharmacology, 1998
- Properties of the pore‐forming P2X7 purinoceptor in mouse NTW8 microglial cellsBritish Journal of Pharmacology, 1997
- Human Monocyte Interleukin-1β Posttranslational ProcessingPublished by Elsevier ,1996
- The Cytolytic P 2Z Receptor for Extracellular ATP Identified as a P 2X Receptor (P2X 7 )Science, 1996
- Post-translational regulation of interleukin 1β secretionCytokine, 1993
- Organization of ligand binding sites at the acetylcholine receptor: a study with monoclonal antibodiesBiochemistry, 1983
- Monoclonal anti-acetylcholine-receptor antibodies directed against the cholinergic binding siteBiochemistry, 1981